CoChat

Intestinal Barrier Dysfunction in a Randomized Trial of a Specific Probiotic Composition in Acute Pancreatitis

Open access
Besselink, Marc G., van Santvoort, Hjalmar C., Renooij, Willem, de Smet, Martin B., Boermeester, Marja A., Fischer, Kathelijn, Timmerman, Harro M., Ahmed Ali, Usama, Cirkel, Geert A., Bollen, Thomas L., van Ramshorst, Bert, Schaapherder, Alexander F., Witteman, Ben J., Ploeg, Rutger J., van Goor, Harry, van Laarhoven, Cornelis J., Tan, Adriaan C., Brink, Menno A., van der Harst, Erwin, Wahab, Peter J., van Eijck, Casper H., Dejong, Cornelis H., van Erpecum, Karel J., Akkermans, Louis M., Gooszen, Hein G. · 2009 · Annals of Surgery
Cited by 181

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

In Brief Objectives: To determine the relation between intestinal barrier dysfunction, bacterial translocation, and clinical outcome in patients with predicted severe acute pancreatitis and the influence of probiotics on these processes. Summary of Background data: Randomized, placebo-controlled, multicenter trial on probiotic prophylaxis (Ecologic 641) in patients with predicted severe acute pancreatitis (PROPATRIA). Methods: Excretion of intestinal fatty acid binding protein (IFABP, a parameter for enterocyte damage), recovery of polyethylene glycols (PEGs, a parameter for intestinal permeability), and excretion of nitric oxide (NOx, a parameter for bacterial translocation) were assessed in urine of 141 patients collected 24 to 48 h after start of probiotic or placebo treatment and 7 days thereafter. Results: IFABP concentrations in the first 72 hours were higher in patients who developed bacteremia (P = 0.03), infected necrosis (P = 0.01), and organ failure (P = 0.008). PEG recovery was higher in patients who developed bacteremia (PEG 4000, P = 0.001), organ failure (PEG 4000, P < 0.0001), or died (PEG 4000, P = 0.009). Probiotic prophylaxis was associated with an increase in IFABP (median 362 vs. 199 pg/mL; P = 0.02), most evidently in patients with organ failure (P = 0.001), and did not influence intestinal permeability. Overall, probiotics decreased NOx (P = 0.05) but, in patients with organ failure, increased NOx (P = 0.001). Conclusions: Bacteremia, infected necrosis, organ failure, and mortality were all associated with intestinal barrier dysfunction early in the course of acute pancreatitis. Overall, prophylaxis with this specific combination of probiotic strains reduced bacterial translocation, but was associated with increased bacterial translocation and enterocyte damage in patients with organ failure. The relation between intestinal barrier dysfunction and clinical outcome was studied in 141 patients with predicted severe acute pancreatitis. Bacteremia, infected necrosis, organ failure, and mortality were all associated with early intestinal barrier dysfunction. Overall, probiotics reduced bacterial translocation, but were associated with enterocyte damage and increased bacterial translocation in patients with organ failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/sla.0b013e3181bce5bd

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Practice guidelines in acute pancreatitis

    Banks, P. A., Freeman, M. L., & the Practice Parameters Committee of the American College of Gastroenterology (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00856.x · Cited by 2,050 · cited 1×

    “Mortality rates vary from 3% for mild pancreatitis to 30% for infected necrotizing pancreatitis.(3) Infections are responsible for most of deaths in acute pancreatitis.”
    Background
  • Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

    Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367 · cited 8×

    “Because the PROPATRIA study included more patients with organ failure than any previous trial on prevention of infectious complications with probiotics, we and others suggested that the negative effect of probiotics could have been restricted to this subgroup of patients with organ failure.(19,20) On the basis of prev…”
    BackgroundResultSelf-citation

Show all 2 references

Cited by

See all 181

Metadata

Authors
Besselink, M. G., van Santvoort, H. C., Renooij, W., de Smet, M. B., Boermeester, M. A., Fischer, K., Timmerman, H. M., Ahmed Ali, U., Cirkel, G. A., Bollen, T. L., van Ramshorst, B., Schaapherder, A. F., Witteman, B. J., Ploeg, R. J., van Goor, H., van Laarhoven, C. J., Tan, A. C., Brink, M. A., van der Harst, E., Wahab, P. J., van Eijck, C. H., Dejong, C. H., van Erpecum, K. J., Akkermans, L. M., & Gooszen, H. G.
Venue
Annals of Surgery
Published
2009-11
Volume
250
Issue
5
Pages
712-719
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2153551421
Cited by
181
References
2
FWCI
13.53
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intestinal Barrier Dysfunction in a Randomized Trial of a Specific Probiotic Composition in Acute Pancreatitis. https://app.cochat.ai/papers/10.1097/sla.0b013e3181bce5bd
The paper
Besselink, M. G., van Santvoort, H. C., Renooij, W., de Smet, M. B., Boermeester, M. A., Fischer, K., Timmerman, H. M., Ahmed Ali, U., Cirkel, G. A., Bollen, T. L., van Ramshorst, B., Schaapherder, A. F., Witteman, B. J., Ploeg, R. J., van Goor, H., van Laarhoven, C. J., Tan, A. C., Brink, M. A., van der Harst, E., . . . Gooszen, H. G. (2009). Intestinal Barrier Dysfunction in a Randomized Trial of a Specific Probiotic Composition in Acute Pancreatitis. Annals of Surgery. https://doi.org/10.1097/sla.0b013e3181bce5bd

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.